当前位置:首页 - 行情中心 - 明德生物(002932) - 财务分析

明德生物

(002932)

  

流通市值:31.20亿  总市值:46.48亿
流通股本:1.56亿   总股本:2.33亿

明德生物(002932)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.83亿元,每股收益0.63元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益639044.95万元,未分配利润443599.71万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产770957.89万元,负债131912.95万元。

利润表
报告期2023-09-302023-06-302023-03-312022-12-31
营业总收入625,927,735.1537,560,328.28372,402,234.8910,530,277,815.19
营业总成本561,146,420.11453,350,326.35305,499,408.614,497,133,738.88
营业利润219,347,804.88170,662,457.7997,778,342.385,079,832,887.61
利润总额214,191,952.11166,672,953.2695,897,834.395,076,397,147.3
净利润182,663,407.68142,001,955.481,455,808.444,380,470,891.05
其他综合收益-3,722,200-0
综合收益总额182,663,407.68145,724,155.481,455,808.444,380,470,891.05
资产负债表
报告期2023-09-302023-06-302023-03-312022-12-31
流动资产合计4,530,267,778.094,850,472,863.677,353,054,345.77,681,848,794.76
非流动资产合计3,179,311,165.653,125,454,307.851,517,096,692.081,509,099,630.96
资产总计7,709,578,943.747,975,927,171.528,870,151,037.789,190,948,425.72
流动负债合计1,255,413,879.281,573,969,005.071,945,217,489.942,364,937,473.34
非流动负债合计63,715,582.5454,462,485.5259,372,307.8154,172,430.21
负债合计1,319,129,461.821,628,431,490.592,004,589,797.752,419,109,903.55
归属于母公司股东权益合计6,081,070,568.196,046,179,165.956,586,507,342.136,499,951,491.53
股东权益合计6,390,449,481.926,347,495,680.936,865,561,240.036,771,838,522.17
负债和股东权益合计7,709,578,943.747,975,927,171.528,870,151,037.789,190,948,425.72
现金流量表
报告期2023-09-302023-06-302023-03-312022-12-31
经营活动现金流入小计1,468,525,956.7923,534,223.23410,773,725.799,091,577,134.41
经营活动现金流出小计1,308,326,996.191,137,826,142.08751,955,751.995,078,728,721.2
经营活动产生的现金流量净额160,198,960.51-214,291,918.85-341,182,026.24,012,848,413.21
投资活动现金流入小计3,022,228,316.162,965,489,412.571,966,234,909.314,387,180,174.04
投资活动现金流出小计2,759,571,302.152,568,442,451.891,003,522,693.896,621,379,522.92
投资活动产生的现金流量净额262,657,014.01397,046,960.68962,712,215.42-2,234,199,348.88
筹资活动现金流入小计19,845,831.519,341,014.3819,845,831.5175,986,411.12
筹资活动现金流出小计632,987,190.37580,006,599.71204,777.73608,776,884.61
筹资活动产生的现金流量净额-613,141,358.87-560,665,585.3319,641,053.77-432,790,473.49
汇率变动对现金及现金等价物的影响1,202,069.491,841,703.34-294,915.619,471,360.64
现金及现金等价物净增加额-189,083,314.86-376,068,840.16640,876,327.391,365,329,951.48
期末现金及现金等价物余额2,366,471,800.492,179,486,275.193,196,431,442.742,555,405,115.35
TOP↑